CrossrefInfokarte
Complement Factor B Blockade by Iptacopan Drives Antitumor Complement-Based Immunomodulation in Pancreatic Cancer Microenvironment
The American Journal of Pathology · 2026-09
DOI: 10.1016/j.ajpath.2026.08.005 ↗Abstract
Kein Abstract verfügbar.
EUVIMED